COCO

The Vita Coco Company, Inc. NASDAQ

Consumer Defensive ·Beverages - Non-Alcoholic ·US · thevitacococompany.com

$67.25

Mkt Cap $3.8B

52w Low $30.54 94.0% of range 52w High $69.58

50d MA $53.07 200d MA $47.11

P/E (TTM) 53.4x

EV/EBITDA 33.8x

P/B 11.5x

Debt/Equity 0.0x

ROE 23.5%

P/FCF 77.3x

RSI (14) —

ATR (14) —

Beta 0.47

50d MA $53.07

200d MA $47.11

Avg Volume 1.4M

About

The Vita Coco Company, Inc. develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers coconut oil and coconut milk; Hydration Drink Mix, a powdered form of flavored coconut water; sparkling water; Runa, a plant-based energy drink; purified water under the Ever & Ever brand…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	BMO	0.34	0.50	+47.1%	51.63	+17.4%	+29.7%	+27.8%	+29.3%	+30.3%	—	—
Feb 18, 2026	BMO	0.13	0.09	-30.8%	56.52	-2.6%	-11.4%	-8.4%	-4.5%	-5.1%	-2.3%	—
Oct 29, 2025	BMO	0.32	0.40	+25.0%	42.24	+9.8%	+7.2%	+0.9%	-2.5%	-3.4%	-5.6%	—
Jul 30, 2025	BMO	0.36	0.38	+5.6%	36.77	+1.8%	+0.0%	-4.1%	-5.5%	-7.9%	-12.2%	—
Apr 30, 2025	BMO	0.22	0.31	+40.9%	31.55	-1.4%	+4.8%	+6.1%	+8.4%	+10.3%	+10.9%	—
Feb 26, 2025	BMO	0.08	0.12	+50.0%	38.16	-12.9%	-11.7%	-15.6%	-15.0%	-14.1%	-12.6%	—
Oct 30, 2024	BMO	0.26	0.32	+23.1%	30.78	+0.7%	-4.0%	-3.8%	+3.9%	+12.4%	+14.6%	—
Jul 31, 2024	BMO	0.29	0.32	+10.3%	24.63	+5.6%	+4.9%	+7.8%	+11.0%	+6.8%	+5.3%	—
May 1, 2024	BMO	0.17	0.24	+41.2%	24.24	+0.0%	+7.9%	+9.2%	+9.4%	+8.8%	+7.3%	—
Feb 28, 2024	BMO	0.08	0.11	+37.5%	22.43	+15.7%	+14.9%	+16.4%	+16.6%	+16.7%	+13.9%	—
Oct 31, 2023	BMO	0.25	0.26	+4.0%	23.37	+11.0%	+16.0%	+20.0%	+21.9%	+23.8%	+23.7%	—
Aug 2, 2023	BMO	0.18	0.31	+72.2%	26.39	+9.7%	-5.0%	-7.2%	-6.9%	+4.5%	+1.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jul 12	Piper Sandler	Downgrade	Overweight → Neutral	—	$30.42	$29.19	-4.0%	-9.1%	-9.6%	-9.3%	-12.9%	-14.8%
Jul 10	Wells Fargo	Maintains	Overweight → Overweight	—	$28.25	$28.53	+1.0%	+6.7%	+7.7%	-2.1%	-2.7%	-2.3%
Jul 10	BofA Securities	Maintains	Neutral → Neutral	—	$28.25	$28.53	+1.0%	+6.7%	+7.7%	-2.1%	-2.7%	-2.3%
May 23	Stephens & Co.	Maintains	Overweight → Overweight	—	$26.23	$26.25	+0.1%	+0.4%	+0.0%	+2.7%	+3.6%	+6.9%
Feb 29	Piper Sandler	Maintains	Overweight → Overweight	—	$25.77	$26.50	+2.8%	+1.3%	+1.5%	+1.6%	-0.9%	-1.9%
Jan 31	Goldman Sachs	Maintains	Buy → Buy	—	$20.24	$20.14	-0.5%	-2.7%	-0.9%	-1.5%	-3.1%	-3.4%
Jan 30	Goldman Sachs	Maintains	Buy → Buy	—	$20.64	$20.55	-0.4%	-1.9%	-4.6%	-2.8%	-3.4%	-5.0%
Jan 26	Piper Sandler	Maintains	Overweight → Overweight	—	$20.96	$20.82	-0.7%	-4.2%	-1.5%	-3.4%	-6.1%	-4.3%
Jan 22	William Blair	Downgrade	Outperform → Market Perform	—	$22.36	$21.50	-3.8%	-6.1%	-6.2%	-6.6%	-6.3%	-10.2%
Nov 1	Piper Sandler	Maintains	Overweight → Overweight	—	$27.10	$27.74	+2.4%	+3.5%	+5.1%	+6.8%	+6.7%	+2.7%
Oct 17	BofA Securities	Maintains	Neutral → Neutral	—	$26.91	$26.28	-2.3%	-4.7%	-7.0%	-8.0%	-8.9%	-7.6%
Aug 3	BofA Securities	Downgrade	Buy → Neutral	—	$25.07	$24.41	-2.6%	-2.3%	-2.0%	+10.1%	+6.3%	+5.6%
Aug 3	Piper Sandler	Maintains	Overweight → Overweight	—	$25.07	$24.41	-2.6%	-2.3%	-2.0%	+10.1%	+6.3%	+5.6%
Aug 3	Goldman Sachs	Maintains	Buy → Buy	—	$25.07	$24.41	-2.6%	-2.3%	-2.0%	+10.1%	+6.3%	+5.6%
May 4	Goldman Sachs	Maintains	Buy → Buy	—	$23.62	$24.00	+1.6%	-2.9%	-4.1%	-1.5%	+3.1%	+3.1%
May 4	Wells Fargo	Maintains	Overweight → Overweight	—	$23.62	$24.00	+1.6%	-2.9%	-4.1%	-1.5%	+3.1%	+3.1%
May 4	Craig-Hallum	Maintains	Buy → Buy	—	$23.62	$24.00	+1.6%	-2.9%	-4.1%	-1.5%	+3.1%	+3.1%
Apr 18	Goldman Sachs	Maintains	Buy → Buy	—	$21.50	$21.53	+0.1%	-3.5%	-3.7%	-3.8%	-3.8%	-5.5%
Apr 17	Goldman Sachs	Maintains	Buy → Buy	—	$21.39	$21.71	+1.5%	+0.5%	-3.0%	-3.2%	-3.3%	-3.3%
Apr 5	Craig-Hallum	Maintains	Buy → Buy	—	$19.60	$20.25	+3.3%	+6.3%	+6.0%	+11.8%	+10.6%	+9.2%
Mar 9	Goldman Sachs	Maintains	Buy → Buy	—	$16.49	$16.90	+2.5%	+6.9%	+2.5%	+0.5%	-0.2%	+2.9%
Mar 9	Wells Fargo	Maintains	Overweight → Overweight	—	$16.49	$16.90	+2.5%	+6.9%	+2.5%	+0.5%	-0.2%	+2.9%
Mar 9	Credit Suisse	Maintains	Outperform → Outperform	—	$16.49	$16.90	+2.5%	+6.9%	+2.5%	+0.5%	-0.2%	+2.9%
Jan 3	Wells Fargo	Maintains	Overweight → Overweight	—	$13.82	$14.11	+2.1%	-2.3%	+0.7%	-0.1%	-2.5%	-1.3%
Dec 15	Piper Sandler	Maintains	Overweight → Overweight	—	$13.25	$13.25	+0.0%	-0.8%	+2.3%	+1.3%	+2.2%	+3.2%
Nov 10	Wells Fargo	Maintains	Overweight → Overweight	—	$8.31	$8.70	+4.7%	+21.5%	+29.0%	+30.0%	+29.5%	+27.6%
Oct 3	Wells Fargo	Maintains	Overweight → Overweight	—	$11.39	$11.39	+0.0%	+3.0%	+8.6%	+7.1%	+8.2%	+4.9%
Aug 11	Credit Suisse	Maintains	Outperform → Outperform	—	$12.32	$12.64	+2.6%	+4.2%	+6.5%	+24.7%	+27.7%	+24.1%
Jul 8	BofA Securities	Upgrade	Neutral → Buy	—	$9.90	$10.77	+8.8%	+11.4%	+18.6%	+19.2%	+19.5%	+13.9%
May 16	Piper Sandler	Maintains	Overweight → Overweight	—	$10.38	$10.38	+0.0%	-1.3%	+2.2%	-6.8%	-3.0%	+0.9%
May 12	Credit Suisse	Maintains	Outperform → Outperform	—	$9.99	$9.41	-5.8%	-9.1%	+3.9%	+2.6%	+6.2%	-3.2%
May 12	Goldman Sachs	Maintains	Buy → Buy	—	$9.99	$9.41	-5.8%	-9.1%	+3.9%	+2.6%	+6.2%	-3.2%
Apr 4	Goldman Sachs	Maintains	Buy → Buy	—	$9.11	$9.11	+0.0%	-1.1%	-2.3%	-4.1%	-2.5%	+1.1%
Mar 14	BofA Securities	Downgrade	Buy → Neutral	—	$8.55	$8.34	-2.5%	-11.6%	-4.2%	+2.6%	+4.2%	+2.9%
Mar 11	Credit Suisse	Maintains	Outperform → Outperform	—	$8.65	$8.80	+1.7%	-1.2%	-12.7%	-5.4%	+1.3%	+2.9%
Mar 11	Wells Fargo	Maintains	Overweight → Overweight	—	$8.65	$8.80	+1.7%	-1.2%	-12.7%	-5.4%	+1.3%	+2.9%
Nov 15	Piper Sandler	Maintains	Overweight → Overweight	—	$14.50	$15.23	+5.0%	+21.2%	+4.8%	+15.2%	+4.2%	+8.6%
Nov 15	Credit Suisse	Maintains	Outperform → Outperform	—	$14.50	$15.23	+5.0%	+21.2%	+4.8%	+15.2%	+4.2%	+8.6%
Nov 15	Evercore ISI	Maintains	Outperform → Outperform	—	$14.50	$15.23	+5.0%	+21.2%	+4.8%	+15.2%	+4.2%	+8.6%
Nov 15	Wells Fargo	Maintains	Overweight → Overweight	—	$14.50	$15.23	+5.0%	+21.2%	+4.8%	+15.2%	+4.2%	+8.6%
Jun 19	Gabelli & Co.	Downgrade	Hold → Sell	—	—	—	—	—	—	—	—	—
May 6	Deutsche Bank	Maintains	Hold → Hold	—	—	—	—	—	—	—	—	—
Feb 5	Compass Point	Maintains	Sell → Sell	—	—	—	—	—	—	—	—	—
Feb 4	Gabelli & Co.	Downgrade	Buy → Hold	—	—	—	—	—	—	—	—	—
Nov 18	Deutsche Bank	Maintains	Hold → Hold	—	—	—	—	—	—	—	—	—
Jan 30	Piper Sandler	Maintains	Neutral → Neutral	—	—	—	—	—	—	—	—	—
Oct 31	Barclays	Maintains	Equal Weight → Equal Weight	—	—	—	—	—	—	—	—	—
Aug 26	Topeka Capital	Maintains	Sell → Sell	—	—	—	—	—	—	—	—	—
Aug 20	Topeka Capital	Maintains	Sell → Sell	—	—	—	—	—	—	—	—	—
Aug 20	Piper Sandler	Maintains	Neutral → Neutral	—	—	—	—	—	—	—	—	—

Recent Filings

8-K

The Vita Coco Company, Inc. -- 8-K Filing

Vita Coco (COCO) reported strong 37% net sales growth to $180 million with net income doubling to $30 million, raising full-year guidance to $720-735 million in sales and $132-138 million in adjusted EBITDA.

Apr 29

8-K

The Vita Coco Company, Inc. -- 8-K Filing

Vita Coco Company filed an 8-K reporting standard corporate disclosure obligations under Exchange Act Section 12(b)-2, with no material operational or financial developments announced in this filing.

Apr 22

8-K

Unknown — 8-K Filing

COCO likely filed routine regulatory disclosure updates required for exchange-listed companies, which carries minimal stock impact unless it signals a material business change or emerging growth company status reclassification.

Apr 10

8-K

The Vita Coco Company, Inc. -- 8-K Filing

Vita Coco (COCO) delivered strong 2025 results with 18% sales growth to $610 million and raised 2026 guidance to $680-700 million, signaling continued momentum in coconut water demand.

Feb 18

Data updated apr 25, 2026 2:26am · Source: massive.com